Family-based financial incentives to help Alaska Native families quit smoking

Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: An RCT

This study tests whether giving financial rewards to Alaska Native families can help them quit smoking better than those who don’t receive rewards.

Quick facts

• Phase: Not applicable
• Study type: Interventional
• Enrollment: 1312 (estimated)
• Ages: 18 Years and up
• Sex: All
• Sponsor: Mayo Clinic (Academic / other)
• Locations: 1 site (Anchorage, Alaska)
• Trial ID: NCT06556433 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of a family-based financial incentive intervention aimed at promoting smoking cessation among Alaska Native/American Indian families. Participants will be divided into two groups: one receiving financial incentives for achieving smoking abstinence and the other receiving no incentives. Both groups will receive evidence-based cessation materials and will be monitored for smoking status over a period of six months. The study aims to assess the impact of family dynamics on smoking cessation outcomes.

Who should consider this trial

Good fit: Ideal candidates are Alaska Native/American Indian adults aged 18 and older who smoke and are willing to make a quit attempt.

Not a fit: Patients who do not identify as Alaska Native/American Indian or those who are not willing to engage in a quit attempt may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve smoking cessation rates among Alaska Native families, leading to better health outcomes.

How similar studies have performed: Previous studies have shown that financial incentives can be effective in promoting smoking cessation, suggesting that this approach may yield positive results.

Eligibility criteria

Index Participant Inclusion Criteria:

* Alaska Native/American Indian (ANAI) person (based on self-reported race) and reside in Alaska.
* Age ≥18 years.
* Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL (positive result based on at-home saliva swab test provided by study team).
* Smoked ≥ 3 cigarettes per day over the past 3 months.
* Considering or willing to make a quit attempt.
* Have or will nominate one adult family member to enroll with them.
* Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration
* Willing to upload photos of self during completion of smoking status tests.
* Willing to complete and sign an Internal Revenue Service (IRS) W-9 tax identification form if they wish to receive payments on the study.
* Willing to provide written informed consent and participate in study-related tests and procedures.

Index Participant Exclusion Criteria:

* Already enrolled in the study with another family member.
* Participated in a prior study phase.

Family Member Participant Inclusion Criteria (regardless of smoking status or residence with the index participant):

* Age ≥18 years.
* Defined as family and nominated by the index participant, or have an ANAI family member who is ≥18 years and smokes that they would like to support in quitting.
* Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration.
* Willing to complete and sign an IRS W-9 tax identification form if they wish to receive payments on the study.
* Willing to provide written informed consent and participate in study related tests and procedures.

Both men and women, those from non-ANAI racial/ethnic groups, and those who live outside of Alaska in the United States will be eligible family member participants.

Family Member Participant Exclusion Criteria:

* Already enrolled with another family member.
* Participated in a prior study phase.

After the randomized controlled trial, qualitative interviews will be conducted with index participants, family member participants, and Alaska Tribal Health System Stakeholders to inform program implementation. Healthcare providers, cessation specialists, Elder advisors, and Tribal Health System leaders and stakeholders will be invited by the Alaska Native Tribal Health Consortium team and separately consented and interviewed.

Where this trial is running

Anchorage, Alaska

• Alaska Native Tribal Health Consortium — Anchorage, Alaska, United States (Recruiting)

Study contacts

• Principal investigator: Christi A Patten, PhD — Mayo Clinic
• Study coordinator: Christi A Patten, PhD

Conditions Smoking Cessation; Alaska Native; Family; Financial Incentive; Contingency Management